We present measurements of galaxy clustering from the Baryon Oscillation Spectroscopic Survey (BOSS), which is part of the Sloan Digital Sky Survey III (SDSS‐III). These use the Data Release 9 (DR9) CMASS sample, which contains 264 283 massive galaxies covering 3275 square degrees with an effective redshift z = 0.57 and redshift range 0.43 < z < 0.7. Assuming a concordance ΛCDM cosmological model, this sample covers an effective volume of 2.2 Gpc3, and represents the largest sample of the Universe ever surveyed at this density, n¯≈3×10−4h−3 Mpc 3. We measure the angle‐averaged galaxy correlation function and power spectrum, including density‐field reconstruction of the baryon acoustic oscillation (BAO) feature. The acoustic features are detected at a significance of 5σ in both the correlation function and power spectrum. Combining with the SDSS‐II luminous red galaxy sample, the detection significance increases to 6.7σ. Fitting for the position of the acoustic features measures the distance to z = 0.57 relative to the sound horizon DV/rs = 13.67 ± 0.22 at z = 0.57. Assuming a fiducial sound horizon of 153.19 Mpc, which matches cosmic microwave background constraints, this corresponds to a distance DV (z = 0.57) = 2094 ± 34 Mpc. At 1.7 per cent, this is the most precise distance constraint ever obtained from a galaxy survey. We place this result alongside previous BAO measurements in a cosmological distance ladder and find excellent agreement with the current supernova measurements. We use these distance measurements to constrain various cosmological models, finding continuing support for a flat Universe with a cosmological constant.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.